jueves, 2 de noviembre de 2023

NIH Statement on Preliminary Efficacy Results of First-in-Class Gonorrhea Antibiotic Developed Through Public-Private Partnership

https://www.niaid.nih.gov/news-events/nih-statement-preliminary-efficacy-results-first-class-gonorrhea-antibiotic-developed?utm_campaign=+58254932&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=

No hay comentarios:

Publicar un comentario